Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

NephroGenex Company Profile (NYSE:NRX)

Consensus Ratings for NephroGenex (NYSE:NRX) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $25.00 (415.46% upside)

Analysts' Ratings History for NephroGenex (NYSE:NRX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/17/2014AegisInitiated CoverageBuy$25.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 9/30/2012 forward)
Discuss NephroGenex